Follow-The-Filings

Security · featured owners

NEO Neogenomics Inc.

Health Care COM NEW Equity as of 2026 Q2 among managers we track

  • 1 exit

NEO (Neogenomics Inc.) 13F ownership among featured managers we track as of 2026 Q2. Figures are as-filed 13F, not free float.

Holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

History
Farallon Capital Management exited 2026 Q2 Last 2026 Q1 <0.01% Exit 0.00% 19,000 $141K History

0 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 13 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 5.02 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K/A 7.01,8.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 1.01,2.03,3.02,8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 12 rows shown

Filed Form Detail Links
4 Period Sep 1, 2026 Filing Doc
4 Period Aug 21, 2026 Filing Doc
4 Period Aug 4, 2026 Filing Doc
4 Period Jun 23, 2026 Filing Doc
4 Period Jun 15, 2026 Filing Doc
4 Period Jun 9, 2026 Filing Doc
4 Period Jun 1, 2026 · 8 forms Filing Doc
4 Period May 11, 2026 · 2 forms Filing Doc
4 Period May 2, 2026 Filing Doc
4 Period May 1, 2026 · 2 forms Filing Doc
4 Period Apr 1, 2026 · 2 forms Filing Doc
4 Period Mar 1, 2026 · 4 forms Filing Doc

Updated 26 days ago Source: SEC EDGAR submissions All on EDGAR

Financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $591.64M $660.57M $727.33M
Gross profit $244.6M $290.1M $314.29M
Gross margin * 41.3% 43.9% 43.2%
Net income -$87.97M -$78.73M -$108.02M
Net margin * -14.9% -11.9% -14.9%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $596.81M $596.02M $376.29M
Total non-current assets $1.08B $1.04B $0.984B
Total assets $1.68B $1.64B $1.36B
Total current liabilities $96.3M $301.24M $88.3M
Total non-current liabilities $643.39M $434.46M $434.97M
Total equity $941.54M $902.34M $836.56M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$1.95M $7.02M $5.23M
Cash from investing $76.71M $12.86M -$12.34M
Cash from financing $4.55M $4.65M -$200.29M
Net change in cash * $79.31M $24.52M -$207.39M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

Ownership over time

filing count by report period · click a bar for that quarter’s holders